Lantheus Investor Relations Material
Latest events
Q4 2023
Lantheus
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Lantheus Holdings Inc
Access all reports
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. Lantheus has commercialized a portfolio of diagnostic tools used during the crucial first hours following myocardial infarction (MI), as well as products for ongoing use in the secondary prevention of cardiovascular disease in patients with established coronary artery disease. Lantheus commercializes its products through strategic relationships with hospital-based distributors and in-country agents.
Key slides for Lantheus Holdings Inc
Q4 2023
Lantheus Holdings Inc
Q4 2023
Lantheus Holdings Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States